XML 50 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHARE-BASED COMPENSATION (Tables)
 9 Months Ended
Jul. 31, 2022
SHARE-BASED COMPENSATION [Abstract]  
Share-based Compensation Expenses The table below presents information on our share-based compensation expenses for the three and nine-month periods ended July 31, 2022, and August 1, 2021.


    Three Months Ended     Nine Months Ended  
   
July 31,
2022
    
August 1,
2021
    
July 31,
2022
   
August 1,
2021
 
                         
Expense reported in:
                        
     Cost of goods sold
  
$
303
    
$
113
     $ 628     $ 322  
     Selling, general and administrative
    
1,115
      
1,076
       3,539       3,380  
     Research and development
    
163
      
122
       456       332  
Total expense incurred
  
$
1,581
    
$
1,311
     $ 4,623     $ 4,034  
                                 
Expense by award type:
                                
     Restricted stock awards
  
$
1,506
    
$
1,219
     $ 4,189     $ 3,703  
     Stock options
    
20
      
37
       279       175  
     Employee stock purchase plan
    
55
      
55
       155       156  
                                 
Total expense incurred
 
$
1,581
    
$
1,311
     $ 4,623     $ 4,034  
                                 
Income tax benefits of share-based compensation
  
$
135
    
$
62
     $ 323     $ 168  
Share-based compensation cost capitalized
  
$
-
    
$
-
     $ -     $ -  
Restricted Stock Awards Activity The table below presents information on our restricted stock awards for the three and nine-month periods ended July 31, 2022, and August 1, 2021.


   
Three Months Ended
     Nine Months Ended  
   
July 31,
2022
    
August 1,
2021
    
July 31,
2022
    
August 1,
2021
 
Number of shares granted in period
    
107,824
      
-
       643,224       556,200  
Weighted-average grant-date fair value of awards (in dollars per share)
  
$
15.95
    
$
-
     $ 18.72     $ 11.17  
Compensation cost not yet recognized
  
$
10,256
    
$
8,467
     $ 10,256     $ 8,467  
Weighted-average amortization period for cost not yet recognized (in years)
    
2.8
      
2.7
       2.8       2.7  
Shares outstanding at balance sheet date
    
916,554
      
973,309
       916,554       973,309  
Stock Options Activity The table below presents information on our stock options for the three and nine-month periods ended July 31, 2022, and August 1, 2021.


   
Three Months Ended
     Nine Months Ended
  
   
July 31,
2022
    
August 1,
2021
    
July 31,
2022
    
August 1,
2021
  
Number of options granted in period
    
-
      
-
       -       -  
Cash received from option exercised
  
$
1,007
    
$
955
     $ 5,157     $ 1,922  
Compensation cost not yet recognized
  
$
33
    
$
160
     $ 33     $ 160  
Weighted-average amortization period for cost not yet recognized (in years)
    
0.5
      
1.2
       0.5       1.2  
Information on Outstanding and Exercisable Option

Information on outstanding and exercisable option awards as of July 31, 2022, is presented below.

Options
  
Shares
  
Weighted
Average
Exercise
Price
  
Weighted
Average
Remaining
Contractual
Life (in years)
  
Aggregate
Intrinsic
Value
  
                       
Outstanding at July 31, 2022
  
626,001
  
$
9.75
  
3.6
  
$
8,803
  
Exercisable at July 31, 2022
  
601,775
  
$
9.75
  
3.4
  
$
8,463